<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00004342</url>
  </required_header>
  <id_info>
    <org_study_id>199/11901</org_study_id>
    <secondary_id>UW-730</secondary_id>
    <nct_id>NCT00004342</nct_id>
  </id_info>
  <brief_title>International Registry for Severe Chronic Neutropenia</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Center for Research Resources (NCRR)</source>
  <brief_summary>
    <textblock>
      OBJECTIVES: I. Document the clinical course of severe chronic neutropenia (SCN).

      II. Monitor and assess long term safety of primary treatment in SCN patients in the United
      States, Canada, Europe, and Australia.

      III. Study the incidence and outcome of adverse events such as osteoporosis, splenomegaly,
      cytogenetic abnormalities, myelodysplastic syndrome, and leukemia.

      IV. Evaluate growth and development and hematologic parameters. V. Monitor for clinically
      significant changes in primary treatment response over time.

      VI. Establish a physician network to increase the understanding of SCN. VII. Establish a
      demographic database to allow for future research.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PROTOCOL OUTLINE:

      Patients are treated by the referring physician as medically indicated. Clinical data are
      collected at baseline and then every 6 months.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 1994</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Natural History</observational_model>
  </study_design_info>
  <enrollment>1000</enrollment>
  <condition>Neutropenia</condition>
  <eligibility>
    <criteria>
      <textblock>
        PROTOCOL ENTRY CRITERIA:

        --Disease Characteristics-- Severe chronic neutropenia (SCN), i.e.: Absolute neutrophil
        count less than 500/mm3 on 3 occasions within the last 3 months (less than 200/mm3 for
        cyclic neutropenia) Bone marrow aspirate consistent with SCN History of infection No drug
        induced neutropenia No myelodysplastic syndrome No aplastic anemia No thrombocytopenia or
        anemia unless due to Shwachman-Diamond syndrome or glycogen storage disease type IB Prior
        enrollment on Amgen SCN trials eligible Bone marrow aspiration within 1 year required
        Cytogenetic evaluation strongly suggested --Prior/Concurrent Therapy-- At least 5 years
        since prior chemotherapy --Patient Characteristics-- No rheumatoid arthritis No systemic
        lupus erythematosus No HIV seropositivity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Chandler Dale</last_name>
    <role>Study Chair</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Women's Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109-0266</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence A. Boxer</last_name>
      <phone>734-764-7127</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Barnabas Medical Center</name>
      <address>
        <city>Livingston</city>
        <state>New Jersey</state>
        <zip>07039</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Mura</last_name>
      <phone>973-322-8076</phone>
      <email>dmura@sbhcs.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Washington School of Medicine</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Chandler Dale</last_name>
      <phone>206-543-7215</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Central Highlands Oncology Program</name>
      <address>
        <city>Ballarat</city>
        <state>Victoria</state>
        <zip>3350</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George Kannourakis</last_name>
      <phone>61-353-334811</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CancerCare Manitoba</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3E 0V9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bonnie Paula Cham</last_name>
      <phone>204-787-4147</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melvin H. Freedman</last_name>
      <phone>416-813-6152</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>D-30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl Welte</last_name>
      <phone>0511-532-6710</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto Giannina Gaslini</name>
      <address>
        <city>Genova</city>
        <zip>16148</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pier G. Mori</last_name>
      <phone>10-5636-331</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. James's Hospital</name>
      <address>
        <city>Leeds</city>
        <state>England</state>
        <zip>LS9 7TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sally Kinsey</last_name>
      <phone>113 243 31 44</phone>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Dale DC, Bonilla MA, Boxer L, et al.: Development of AML/MDS in a subset of patients (PTS) with severe chronic neutropenia (SCN). Blood 84(10 suppl 1): 518a, 1994.</citation>
  </reference>
  <reference>
    <citation>Guerra J, Withers DA, Boxer LM. Myb binding sites mediate negative regulation of c-myb expression in T-cell lines. Blood. 1995 Sep 1;86(5):1873-80.</citation>
    <PMID>7655015</PMID>
  </reference>
  <reference>
    <citation>Welte K, Dale D. Pathophysiology and treatment of severe chronic neutropenia. Ann Hematol. 1996 Apr;72(4):158-65. Review.</citation>
    <PMID>8624368</PMID>
  </reference>
  <reference>
    <citation>Kalra R, Dale D, Freedman M, Bonilla MA, Weinblatt M, Ganser A, Bowman P, Abish S, Priest J, Oseas RS, Olson K, Paderanga D, Shannon K. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. Blood. 1995 Dec 15;86(12):4579-86.</citation>
    <PMID>8541548</PMID>
  </reference>
  <verification_date>December 2003</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 1999</study_first_submitted>
  <study_first_submitted_qc>October 18, 1999</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 1999</study_first_posted>
  <last_update_submitted>June 23, 2005</last_update_submitted>
  <last_update_submitted_qc>June 23, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2005</last_update_posted>
  <keyword>chronic neutropenia</keyword>
  <keyword>disease-related problem/condition</keyword>
  <keyword>hematologic disorders</keyword>
  <keyword>neutropenia</keyword>
  <keyword>rare disease</keyword>
  <keyword>severe chronic neutropenia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neutropenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

